Background: Nonsustained ventricular tachycardia (NSVT) is sometimes observed in patients with neuromuscular diseases (NMDs). The aim of this study was to assess the role of NSVT in the survival prognosis of NMD patients.
| INTRODUCTION
There have been many studies that aimed to reveal the role of neuromuscular dysfunction on the regulation of the heart beat and cardiac rhythm. Davis et al 1 suggested that the neuroanatomic connections between the neuromuscular system and heart might provide the links that generate cardiac arrhythmias in response to brain activation. They suggested the neuromuscular system directs the events that lead to cardiac damage by raising catecholamine levels and potentially inducing arrhythmia.
Patients with neuromuscular diseases (NMDs) exhibit various types of arrhythmia. For example, Harper and Pelargonio et al 2, 3 reviewed the heart problems in myotonic dystrophy. In myotonic dystrophy, various electrocardiographic abnormalities, most commonly atrioventricular block, were reported. 4, 5 According to Wahbi et al, 6 sustained ventricular tachycardia (VT) in patients with myotonic dystrophy type 1 might be a predictor of sudden death.
Nonsustained ventricular tachycardia (NSVT) is more common than VT in the general population, and little is known about the prognostic significance of NSVT in patients with NMDs.
Therefore, we have started clinical research on the prognostic significance of NSVT in patients who were hospitalized for life under the National Hospital Care Program for NMDs in Japan. 7 Our aim was to conclude whether NSVT in those patients with advanced
NMDs is a large concern for their prognosis or not.
2 | ME TH ODS
| Study participants
The protocol for this retrospective study has been approved by a suitably constituted Ethics Committee of the institution, and it con- Figure 1 . The outcomes were assessed after a 5 year follow-up.
| Clinical outcomes
Cardiac death was defined as acute coronary syndrome, heart failure, sustained ventricular tachycardia, ventricular fibrillation, or sudden death. Sudden death included the following: (i) occurring within 1 hour of the onset of cardiac manifestations, in the absence of prior hemodynamic deterioration, (ii) during sleep, or (iii) within 24 hours after the patient was last seen to be clinically stable. 9 The long-term outcome was assessed as the cumulative survival rate after Holter ECG.
| Statistical analyses
Continuous variables are shown as a mean AE SD, whereas categorical variables are reported as a number or percentage. Cumulative event-free survival (all cause of death and cardiac death) was estimated using the Kaplan-Meier method, and event-free survival among groups was compared using the log-rank test. The prediction accuracy of the models (total beats, age, and ejection fraction) was evaluated using the receiver-operating characteristic (ROC) curve.
We adjusted the cumulative event-free survival by age and ejection fraction (EF). All statistical analyses were performed with EZR (Saitama Medical Center, Jichi Medical University, Saitama, Japan), which is a graphical user interface for R (The R Foundation for 
| 255
Statistical Computing, Vienna, Austria). More precisely, it is a modified version of R Commander designed to add statistical functions and is frequently used in biostatistics. 10 3 | RESULTS
| Baseline characteristics
The relationship between the NSVT and the prognosis was observed in 68 patients with NMDs. Baseline characteristics are presented in 
| Clinical outcomes during follow-up
During a mean follow-up of 56 AE 20 months after a Holter ECG, 21
patients died, of whom 7 cases were regarded as a cardiac death.
The most frequent cause of death was infection, which was found in 8 cases. The second most frequent cause of death was cardiac death, including 4 sudden deaths, 1 acute coronary syndrome, 1 VT storm, and 1 heart failure. One patient who died by VT storm had NSVT in Holter ECG. Other causes of death included 1 stroke, 1 malnutrition, 1 dehydration, and 1 aspiration problem, and 3 patients died of unknown causes. Figure 2A shows the Kaplan-Meier survival curve that compared the patients with NSVT and those without NSVT, and the NSVT was not related to the rate of all causes of death in patients with NMDs.
The survival curve for cardiac death did not show a significant difference in the two groups ( Figure 2B ).
Other factors as well as NSVT were also evaluated by the univariate analysis (Table 3 ). The cut-off value of the age, total beats, (Table 2 ). But the survival curves were not significantly changed after the adjustment by age and EF. The survival curves adjusted by the age were shown in Figure 3 (all causes of death: Figure 3A, cardiac death: Figure 3B ). Those adjusted by EF were shown in Figure 4 (all causes of death: Figure 4A , cardiac death: Figure 4B ).
In this context, the above statistical analyses indicated that cardiac death and all causes of death were not influenced by the age, gender, and so on. 12 In general, patients with NSVT require an evaluation for structural cardiovascular disorders such as coronary, valvular, and myocardial disorders, 13 but the prognostic significance of spontaneous NSVT in healthy individuals has not been established. 14 For example, the previous report suggested an association between mortality and NSVT in patients with cardiac hypertrophy. 15 Moreover, a negative impact of NSVT was suggested in patients with reduced EF and those with coronary artery diseases, for whom an implantable cardioverter defibrillator would be mandatory. 16 But, in the patients with a permanent implanted cardiac pacemaker, NSVT was not associated with an increased mortality. 17 Our aim was to decide whether NSVT had a significant influence on the prognosis of these NMD patients. This study has demonstrated that NSVT diagnosed with the Holter ECG was not significantly associated with patients' survival.
The previous multivariate analysis indicated that only the EF was a significant predictor of major arrhythmic events. 18 In fact, in our study, the EF was significantly different between the patients with NSVT and those without NSVT. Therefore, we adjusted the survival curve by the EF, and we confirmed that the co-existence of NSVT had no influence on the prognosis.
The usual work-up for patients with NSVT might rule out structural heart disease, using ECG, echocardiogram, cardiac magnetic resonance imaging (MRI), and cardiac catheterization in some cases. 19 However, many of these patients could have advanced NMDs with severe motor, sensory, and respiratory dysfunction and might have difficulties in undertaking the detailed cardiac examinations with MRI and catheterization in a separate institute of cardiology.
In this study, the most prevalent cause of death was infection, such as aspiration pneumonia. Many patients with advanced NMDs could have swallowing difficulties, restrictive respiratory insufficiency, respiratory failure, and sleep apnea. 20 We suggest that the prognosis of patients with NMDs is not determined by their heart 
| Limitation
Regarding the limitations on this study, first of all, this was a singlecenter, retrospective study, and bias could be inherent in this type NMDs and actively involved in daily medical practice. Hence, the authors hope that large-scale studies might be possible, and the relationship between arrhythmia and NMDs might be revealed.
| CONCLUSION
No significant correlations between the NSVT and the prognosis in patients with NMDs were found.
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